Profound retinal ischaemia after ranibizumab administration in an eye with ocular ischaemic syndrome.
To report the result of ranibizumab administration in an eye with ocular ischaemic syndrome. Fluorescein angiography, ocular pneumoplethysmography and retinal vessel calibre measurement. An 85-year-old man with ocular ischaemic syndrome demonstrated vision loss, retinal vessel calibre constriction and profound retinal ischaemia after intravitreal ranibizumab. We advise against the use of intravitreal vascular endothelial growth factor inhibitors in eyes with ocular ischaemic syndrome.